Rocket Pharmaceuticals, Inc.
RCKT
$3.47
$0.133.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 123.21M | -47.59M | -42.54M | -50.33M | -68.92M |
| Total Depreciation and Amortization | 2.10M | 2.15M | 2.22M | 3.24M | 2.58M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -171.41M | 7.47M | 5.29M | 8.16M | 8.65M |
| Change in Net Operating Assets | 6.48M | -7.42M | 195.00K | -11.49M | 8.73M |
| Cash from Operations | -39.61M | -45.39M | -34.84M | -50.42M | -48.96M |
| Capital Expenditure | -8.00K | -93.00K | -80.00K | 54.00K | -50.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 214.37M | 17.54M | 36.51M | 93.56M | 31.81M |
| Cash from Investing | 214.36M | 17.45M | 36.43M | 93.62M | 31.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.00K | -1.00K | -- | -- | -- |
| Issuance of Common Stock | 152.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 0.00 | -67.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 215.00K |
| Cash from Financing | 150.00K | -1.00K | 0.00 | -67.00K | 215.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 174.90M | -27.95M | 1.59M | 43.13M | -16.99M |